Analyst Reco. Maravai LifeSciences Holdings, Inc.

Equities

MRVI

US56600D1072

Market Closed - Nasdaq Other stock markets 16:00:00 2024-04-26 EDT			5-day change	1st Jan Change
7.7 ^USD	+1.58%		+5.48%	+17.56%

04-18	Maravai LifeSciences Unit Opens New Manufacturing Facility in San Diego	MT
04-10	Craig-Hallum Initiates Coverage on Maravai LifeSciences With Buy Rating, $15 Price Target	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Craig-Hallum Initiates Coverage on Maravai LifeSciences With Buy Rating, $15 Price Target	04-10	MT
RBC Raises Price Target on Maravai LifeSciences Holdings to $15 From $14, Keeps Outperform Rating	04-08	MT
UBS Adjusts Maravai LifeSciences Price Target to $6.50 From $6, Maintains Neutral Rating	02-23	MT
Stifel Trims Price Target on Maravai LifeSciences to $10 From $11, Maintains Buy Rating	02-23	MT
RBC Raises Price Target on Maravai LifeSciences Holdings to $14 From $12, Cites 'Clean' Q4, Keeps Outperform Rating	02-23	MT
BofA Securities Upgrades Maravai LifeSciences to Buy From Neutral	12-12	MT
Goldman Sachs Trims Maravai LifeSciences Holdings' Price Target to $7 From $8, Maintains Neutral Rating	11-09	MT
Morgan Stanley Trims Price Target on Maravai LifeSciences to $11 From $12, Maintains Overweight Rating	11-09	MT
UBS Adjusts Maravai LifeSciences Price Target to $6 From $12, Maintains Neutral Rating	11-08	MT
Deutsche Bank Adjusts Maravai LifeSciences Price Target to $10 From $17, Maintains Buy Rating	11-08	MT
UBS Trims Price Target on Maravai LifeSciences to $12 From $12.75, Reiterates Neutral Rating	23-09-29	MT
UBS Adjusts Maravai LifeSciences Price Target to $12.75 From $14, Maintains Neutral Rating	23-08-09	MT
Deutsche Bank Adjusts Maravai LifeSciences Price Target to $17 From $23, Maintains Buy Rating	23-08-08	MT
Morgan Stanley Adjusts Price Target on Maravai LifeSciences to $12 From $27, Keeps Overweight Rating	23-08-08	MT
Stifel Adjusts Price Target on Maravai LifeSciences to $12 From $17, Keeps Buy Rating	23-08-08	MT
Goldman Sachs Adjusts Price Target on Maravai LifeSciences to $8 From $12, Keeps Neutral Rating	23-08-08	MT
Baird Adjusts Price Target on Maravai LifeSciences to $11 From $18, Keeps Outperform Rating	23-08-08	MT
Credit Suisse Adjusts Maravai LifeSciences Holdings' Price Target to $11 From $14, Keeps Neutral Rating	23-08-08	MT
RBC Cuts Price Target on Maravai LifeSciences Holdings to $18 From $20 Amid Lower Guidance, Keeps Outperform Rating	23-08-08	MT
KeyBanc Downgrades Maravai LifeSciences Holdings to Sector Weight From Overweight Amid Limited Visibility, Lack of Catalysts	23-08-08	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Maravai LifeSciences Holdings, Inc.

Equities

MRVI

US56600D1072

Analyst Reco.

Filters